Capital Advisors Ltd’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Sell
65
-1
-2% -$214 ﹤0.01% 778
2026
Q1
$15K Hold
66
﹤0.01% 742
2025
Q4
$17K Hold
66
﹤0.01% 691
2025
Q3
$16K Hold
66
﹤0.01% 699
2025
Q2
$16K Sell
66
-39
-37% -$9.08K ﹤0.01% 685
2025
Q1
$24K Buy
105
+39
+59% +$8.58K ﹤0.01% 587
2024
Q4
$14K Buy
66
+1
+2% +$219 ﹤0.01% 708
2024
Q3
$16K Hold
65
﹤0.01% 660
2024
Q2
$14K Buy
65
+63
+3,150% +$13.7K ﹤0.01% 681
2024
Q1
$0 Buy
+2
New +$451 ﹤0.01% 1536
2023
Q2
Sell
-1
Closed 1531
2023
Q1
$0 Buy
+1
New +$193 ﹤0.01% 1537
2022
Q4
Sell
-8
Closed -$1K 1618
2022
Q3
$1K Buy
8
+2
+33% +$407 ﹤0.01% 1123
2022
Q2
$1K Buy
+6
New +$1.35K ﹤0.01% 889
2022
Q1
Sell
-21
Closed -$5K 1187
2021
Q4
$5K Buy
21
+1
+5% +$228 ﹤0.01% 576
2021
Q3
$4K Hold
20
﹤0.01% 480
2021
Q2
$4K Hold
20
﹤0.01% 460
2021
Q1
$4K Hold
20
﹤0.01% 460
2020
Q4
$4K Hold
20
﹤0.01% 428
2020
Q3
$4K Hold
20
﹤0.01% 427
2020
Q2
$3K Buy
+20
New +$3.05K ﹤0.01% 430

Other funds holding STE

Capital Advisors Ltd's STE Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Steris (STE) stake by 1.5% in Q2 2026, selling an estimated $214 and leaving 65 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Capital Advisors Ltd first reported a position in STE in Q2 2020 and has held it in 20 quarters since. The position peaked at $24K in Q1 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Capital Advisors Ltd held 65 shares of Steris worth $14K as of Q2 2026.
  • Capital Advisors Ltd sold 1 Steris share in Q2 2026, an estimated $214.
  • Steris made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #778 holding.
  • Capital Advisors Ltd first reported a position in Steris in Q2 2020 and has held it in 20 quarters since.
  • Capital Advisors Ltd's Steris position peaked at $24K in Q1 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.